Canada · Delayed Price · Currency is CAD MYND Life Sciences Statistics
Total Valuation
CSE:MYND has a market cap or net worth of CAD 5.22 million. The enterprise value is 8.22 million.
| Market Cap | 5.22M |
| Enterprise Value | 8.22M |
Important Dates
The next estimated earnings date is Friday, March 6, 2026.
| Earnings Date | Mar 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:MYND has 74.55 million shares outstanding.
| Current Share Class | 74.55M |
| Shares Outstanding | 74.55M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5,218,346.00 |
| PB Ratio | -0.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.15 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.47 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -151.46% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 21.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +133.33% in the last 52 weeks. The beta is 1.13, so CSE:MYND's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +133.33% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 65.24 |
| Average Volume (20 Days) | 100 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:MYND had revenue of CAD 1 and -542,565 in losses. Loss per share was -0.01.
| Revenue | 1 |
| Gross Profit | -331,778 |
| Operating Income | -1.29M |
| Pretax Income | -542,565 |
| Net Income | -542,565 |
| EBITDA | -1.28M |
| EBIT | -1.29M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 497 in cash and 3.00 million in debt, giving a net cash position of -3.00 million or -0.04 per share.
| Cash & Cash Equivalents | 497 |
| Total Debt | 3.00M |
| Net Cash | -3.00M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | -5.99M |
| Book Value Per Share | -0.13 |
| Working Capital | -6.09M |
Cash Flow
| Operating Cash Flow | -172,775 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -128,598,000.00% |
| Pretax Margin | -54,256,500.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:MYND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.92% |
| Shareholder Yield | 0.92% |
| Earnings Yield | -10.40% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CSE:MYND has an Altman Z-Score of -36.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -36.38 |
| Piotroski F-Score | 2 |